Macarthur Joshua Ian, Hannan Cathal John, Howard Callum, Halliday Jane, Pathmanaban Omar Nathan, Hammerbeck-Ward Charlotte, Rutherford Scott A, King Andrew T
Faculty of Biology, Medicine, and Health, University of Manchester, Manchester, United Kingdom.
Department of Neurosurgery, Manchester Centre for Clinical Neurosciences, Manchester, United Kingdom.
J Neurol Surg B Skull Base. 2024 Apr 30;86(3):245-253. doi: 10.1055/s-0044-1786370. eCollection 2025 Jun.
Skull base meningiomas (SBMs) are often subtotally resected and there is a paucity of evidence regarding the long-term rates of postoperative tumor progression. We aimed to investigate the factors that influence tumor recurrence in patients with an extended period of follow-up. Surgically resected tumors with long-term radiological follow-up were included for analysis. Data were collected on patient demographics, anatomical location, Simpson grade, World Health Organization (WHO) grade, modality of reintervention, and functional status. Recurrence was defined as tumor progression requiring intervention. Kaplan-Meier method and log-rank test were used to calculate recurrence-free probability. Cox regression analysis was used to determine factors associated with tumor progression. Sixty-one patients were identified. Median radiological follow-up was 11.25 (IQR 4.3) years. Median age at first surgery was 50 (IQR 17) years. A total of 55/61(90%) tumors were WHO grade I and 6/61(10%) were grade II. Gross total resection (GTR) was achieved in 37/61 (60.7%) patients with subtotal resection (STR) in 24/61 (39.3%). In total, 28/61(45.9%) demonstrated recurrence/regrowth with a median time to recurrence of 2.8 (IQR 5) years. Also, 15/37 (40.5%) and 13/24 (54.2%) patients with GTR and STR, respectively, had tumor recurrence. Of the 28 recurrences, 4/28 (14.3%) underwent reresection, 9/28 (32.1%) were managed with radiotherapy, and 15/28 (53.6%) received both reresection and radiotherapy. Tumor grade was the only significant predictor of tumor recurrence ( = 0.033). Neurological function at last follow-up was significantly worse (modified Rankin scale >2) in patients with recurrence ( = 0.035). Surgically resected SBMs are associated with a significant recurrence rate during prolonged follow-up, irrespective of the extent of resection achieved. We recommend a prolonged period of radiological surveillance for SBM following surgical resection.
颅底脑膜瘤(SBMs)通常只能次全切除,关于术后肿瘤长期进展率的证据很少。我们旨在调查在长期随访患者中影响肿瘤复发的因素。
纳入经手术切除且有长期影像学随访的肿瘤进行分析。收集患者人口统计学资料、解剖位置、辛普森分级、世界卫生组织(WHO)分级、再次干预方式和功能状态等数据。复发定义为需要干预的肿瘤进展。采用Kaplan-Meier法和对数秩检验计算无复发生存概率。采用Cox回归分析确定与肿瘤进展相关的因素。
共纳入61例患者。影像学随访的中位时间为11.25(四分位间距4.3)年。首次手术时的中位年龄为50(四分位间距17)岁。61例肿瘤中,55/61(90%)为WHO I级,6/61(10%)为II级。61例患者中,37/61(60.7%)实现了全切(GTR),24/61(39.3%)为次全切(STR)。总体而言,61例中有28/61(45.9%)出现复发/再生长,复发的中位时间为2.8(四分位间距5)年。此外,GTR组和STR组分别有15/37(40.5%)和13/24(54.2%)的患者出现肿瘤复发。在28例复发患者中,4/28(14.3%)接受了再次切除,9/28(32.1%)接受了放疗,15/28(53.6%)同时接受了再次切除和放疗。肿瘤分级是肿瘤复发的唯一显著预测因素(P = 0.033)。复发患者最后一次随访时的神经功能明显较差(改良Rankin量表评分>2)(P = 0.035)。
手术切除的SBMs在长期随访期间有显著的复发率,无论切除范围如何。我们建议对手术切除后的SBMs进行长期的影像学监测。